Synthesize Bio, a biotechnology company pioneering biological foundation models to simulate the results of gene expression experiments, announced a $10 million seed round led by Madrona, with participation from Sahsen Ventures, Inner Loop Capital, Point Field Partners, and AI2 Incubator. The funding will accelerate the development of Synthesize Bio's generative genomics models and expand access for biopharmaceutical companies and researchers.